FDA Adverse Event Injury Summary report: N

PUREVISION

MDR report key: 400103 · Received June 17, 2002

Report

Report Number
1313525-2002-00009
Event Type
Injury
Date Received
June 17, 2002
Report Date
May 20, 2002
Manufacturer
BAUSCH & LOMB INC
Product Code
LPL
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 1

ARTICLE IN THE BRITISH JOURNAL OF OPHTHALMOLOGY (2002;86:350-362) REPORTS A PT PRESENTED WITH A 2 DAY HISTORY OF RIGHT EYE INJECTION, PAIN, PHOTOPHOBIA, AND DECREASED VISION. PT WAS WEARING CONTACT LENSES ON A DAILY WEAR BASIS BUT CHANGED TO CONTINUOUS WEAR 24 HOURS BEFORE THE ONSET OF THEIR SYMPTOMS. EXAMINATION REVEALED MARKED RIGHT EYE CILLARY INJECTION AND ANTERIOR CHAMBER ACTIVITY WITH CELLS, FLARE, MULTIPLE SCATTERED KPS, AND A SMALL PARACENTRAL EPITHELIAL DEFECT WITH UNDERLYING INFILTRATE. CORNEAL SCRAPINGS CONFIRMED MICROBIAL KERATITIS. TOPICAL CIPROFLOXSCIN 0.3% WAS ADMINISTERED HOURLY WITH THE ADDITION OF TOPICAL FLUOROMETHALINE ACETATE 0.31% Q.I.D. AFTER CLINICAL IMPROVEMENT 24 HRS LATER. ALL TREATMENT WAS TAPERED AND CEASED AFTER 2 WEEKS. THE PT FAILED TO RETURN FOR FOLLOWUP, HOWEVER, IN CONTACT BY PHONE THE PT REPORTED TO THE PRACTITIONER THAT THEIR VISION HAD RETURNED TO NORMAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PUREVISION SOFT CONTACT LENS LPL BAUSCH & LOMB INC NA UNK

Patients

Seq Age Sex Outcome Treatment
1 21 YR Required Intervention